MedTrace Logo

Effects of Motor Imagery and Action Observation on Electromyographic Activity and Intramuscular Oxygenation in the Hand Gripping Gesture

NCT03324217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-30

No results posted yet for this study

Summary

Motor imagery is defined as a dynamic mental process of an action, without its real motor execution. Action observation training consists of watching an action performed by someone else. The primary objective of this study was to evaluate the effects of motor imagery and action observation combined with a hand grip strength program on strength gains in asymptomatic participants. The secondary objective was to assess the influence of motor imagery and action observation training combined with a hand grip strength program on electromyographic activity and intramuscular oxygenation of the forearm muscles.

Conditions

Interventions

OTHER

Mental Practise

They made a mental task to produce a neurophysiological activation of the brain areas related to the planning and execution of voluntary movement in a manner that resembles how the action is performed in reality in combination with real exercises.

Sponsors & Collaborators

  • Universidad Autonoma de Madrid

    lead OTHER

Principal Investigators

  • Roy A La Touche, PT, PhD · Departamento de Fisioterapia. Centro Superior de Estudios Universitarios de La Salle. Universidad Autónoma de Madrid. Madrid. Spain

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2017-09-11
Completion
2017-10-13

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03324217 on ClinicalTrials.gov